Developing Novel Drugs for Stroke, ALS, and Wound Healing

ZZ Biotech, LLC - Developing Innovative Biologic Treatments

ZZ Biotech is a clinical stage biopharmaceutical company advancing new treatments for some of the biggest unmet needs in stroke, neurodegenerative disease and chronic wound healing. Our lead drug, 3K3A-APC, is a genetically engineered variant of human activated protein C (APC), a serine protease. 3K3A-APC was designed to enhance the cytoprotective and anti-inflammatory activities of APC while greatly reducing its anti-coagulant activity.